Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I W Flinn

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphomaJ G Berdeja, R J Jones, M L Zahurak, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicityJ C Byrd, T Murphy, R S Howard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphomaY L Kasamon, R J Jones, R A Brodsky, et al.
Leukemia|June 16, 2012
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-upR A Larson, A Hochhaus, T P Hughes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trialA S Cottereau, L Rebaud, J Trotman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphomaJ G Berdeja, R J Jones, M L Zahurak, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicityJ C Byrd, T Murphy, R S Howard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphomaY L Kasamon, R J Jones, R A Brodsky, et al.
Leukemia|June 16, 2012
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-upR A Larson, A Hochhaus, T P Hughes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trialA S Cottereau, L Rebaud, J Trotman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.
Pageof 4